[1]
2026. Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Jan. 2026), e2026001. DOI:https://doi.org/10.4084/MJHID.2026.001.